Gefei He
- Topics
- COVID-19 Clinical Research Studies (4 papers)Antibiotics Pharmacokinetics and Efficacy (4 papers)Pharmacovigilance and Adverse Drug Reactions (4 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Gefei He
22 papers receiving 274 citations
Peers
Comparison fields: 5 of 82
- Infectious Diseases 102
- Molecular Biology 51
- Physiology 51
- Pharmacology 45
- Neurology 38
Countries citing papers authored by Gefei He
This map shows the geographic impact of Gefei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gefei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gefei He more than expected).
Fields of papers citing papers by Gefei He
This network shows the impact of papers produced by Gefei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gefei He. The network helps show where Gefei He may publish in the future.
Co-authorship network of co-authors of Gefei He
This figure shows the co-authorship network connecting the top 25 collaborators of Gefei He. A scholar is included among the top collaborators of Gefei He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gefei He. Gefei He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 28 | |
| 9 | 3 | |
| 10 | 3 | |
| 11 | 3 | |
| 12 | 1 | |
| 13 | 8 | |
| 14 | 1 | |
| 15 | 15 | |
| 16 | 17 | |
| 17 | 8 | |
| 18 | 31 | |
| 19 | 73 | |
| 20 | 65 |
About Gefei He
Gefei He is a scholar working on Toxicology, Applied Microbiology and Biotechnology and Geriatrics and Gerontology, having authored 22 papers that have together received 278 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Pharmacovigilance and Adverse Drug Reactions (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (24 citations), Toxicology (26 citations) and Molecular Medicine (29 citations). Gefei He has collaborated with scholars based in China and United States. Frequent co-authors include Juanjuan Huang, Ji Su Sun, Jiyang Liu, Xiaoping Chen, Jinhui Feng, Yanfei Li, Qiang Qu, Jian Qu, Qiong Lu and Qiong Chen. Their work appears in journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.